Invasive group a streptococcal infections, Israel
Related Experiment Video
Updated: Oct 1, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
Allon E Moses1, Sara Goldberg, Zinaida Korenman
1Hadassah University Medical Center, Jerusalem, Isreal. MOSESA@MD2.HUJI.AC.IL
Abstract:
We conducted a prospective, nationwide, population-based study of invasive group A streptococcal infections in Israel. We identified 409 patients (median age 27 years; range <1-92), for an annual incidence of 3.7/100,000 (11/100,000 in Jerusalem). The mortality rate was 5%. Bacteremia occurred in 125 cases (31%). The most common illnesses were soft-tissue infection (63%) and primary bacteremia (14%). Thirty percent of patients had no identifiable risk factors for infection. Eighty-seven percent of pharyngeal carriers had the same serotype as the index patient. M types included M3 (25%), M28 (10%), and M-nontypable (33%). A marked paucity of M1 serotype (1.2%) was detected. The results highlighted concentrated pockets of invasive disease in the Jewish orthodox community (annual incidence 16/100,000).
Related Concept Videos
Streptococcal Pharyngitis
Staphylococcal Skin Infections
Rheumatic Heart Disease I: Introduction
Endocarditis I: Introduction
Rheumatic Heart Disease III: Medical Management
Sexually Transmitted Infections
